Tighter Clinical Practices Near For Medical Device Trials in China
This article was originally published in Clinica
Sites in China that participate in medical device studies will have to keep all clinical data and materials for a period of ten years after the completion of a study, according to tighter good clinical practice (GCP) provisions that are due to take effect in the country on June 1.
You may also be interested in...
A number of new products have been submitted for review at the European Medicines Agency. While marketing authorization applications from ViiV Healthcare and BioMarin Pharmaceutical are being fast-tracked, a submission from Incyte is not.
Medtronic Wins In England’s NICE Decision On Implantable Monitors For Stroke Patients; Biotronik And Abbott Lose
UK health technology assessment body NICE says that Medtronic’s Reveal LINQ, which transmits data remotely to doctors, is likely to be a cost-effective use of National Health Service resources.
Using the QALY is expected to help the Danish Medicines Council make its decisions on the cost effectiveness of drugs more transparent, but it will also extend the time the council takes to make a recommendation.